US Patent Issued to Gongwin Biopharm on Sept. 22 for "Benzenesulfonamide derivatives and method for modulating lipid raft" (Taiwanese, Chinese Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,740,952, issued on Sept. 22, was assigned to Gongwin Biopharm Co. Ltd. (Taipei City, Taiwan).

"Benzenesulfonamide derivatives and method for modulating lipid raft" was invented by Chuan-Ching Yang (Taipei City, Taiwan), Mao-Yuan Lin (Taipei City, Taiwan), Shun-Chi Wu (Taipei City, Taiwan), Chi-Chiang Tu (Taipei City, Taiwan) and Nan-Shan Zhong (Guangzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a benzenesulfonamide derivative which is useful to modulate lipid raft integrity of cancer cells and the use of the benzenesulfonamide derivative in prevention or treatment of diseases or conditions which can be ame...